Literature DB >> 22550065

Evaluation of a mathematical model of diabetes progression against observations in the Diabetes Prevention Program.

Thomas Hardy1, Eyas Abu-Raddad, Niels Porksen, Andrea De Gaetano.   

Abstract

The seminal publication of the Diabetes Prevention Program (DPP) results in 2002 has provided insight into the impact of major therapies on the development of diabetes over a time span of a few years. In the present work, the publicly available DPP data set is used to calibrate and evaluate a recently developed mechanistic mathematical model for the long-term development of diabetes to assess the model's ability to predict the natural history of disease progression and the effectiveness of preventive interventions. A general population is generated from which virtual subject samples corresponding to the DPP enrollment criteria are selected. The model is able to reproduce with good fidelity the observed time courses of both diabetes incidence and average glycemia, under realistic hypotheses on evolution of disease and efficacy of the studied therapies, for all treatment arms. Model-based simulations of the long-term evolution of the disease are consistent with the transient benefits observed with conventional therapies and with promising effects of radical improvement of insulin sensitivity (as by metabolic surgery) or of β-cell protection. The mechanistic diabetes progression model provides a credible tool by which long-term implications of antidiabetic interventions can be evaluated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22550065     DOI: 10.1152/ajpendo.00421.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  11 in total

1.  A glycemia-structured population model.

Authors:  Alessandro Borri; Simona Panunzi; Andrea De Gaetano
Journal:  J Math Biol       Date:  2015-10-06       Impact factor: 2.259

Review 2.  Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.

Authors:  Jane P F Bai; Justin C Earp; Venkateswaran C Pillai
Journal:  AAPS J       Date:  2019-06-03       Impact factor: 4.009

3.  Type 2 diabetes: one disease, many pathways.

Authors:  Joon Ha; Arthur Sherman
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-07-14       Impact factor: 4.310

Review 4.  Requirements for multi-level systems pharmacology models to reach end-usage: the case of type 2 diabetes.

Authors:  Elin Nyman; Yvonne J W Rozendaal; Gabriel Helmlinger; Bengt Hamrén; Maria C Kjellsson; Peter Strålfors; Natal A W van Riel; Peter Gennemark; Gunnar Cedersund
Journal:  Interface Focus       Date:  2016-04-06       Impact factor: 3.906

Review 5.  Quantitative system pharmacology as a legitimate approach to examine extrapolation strategies used to support pediatric drug development.

Authors:  Karim Azer; Jeffrey S Barrett
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-05-24

6.  Effects of IL-1β-Blocking Therapies in Type 2 Diabetes Mellitus: A Quantitative Systems Pharmacology Modeling Approach to Explore Underlying Mechanisms.

Authors:  R Palmér; E Nyman; M Penney; A Marley; G Cedersund; B Agoram
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-06-11

7.  Mathematical model of blood glucose dynamics by emulating the pathophysiology of glucose metabolism in type 2 diabetes mellitus.

Authors:  Nelida Elizabeth López-Palau; José Manuel Olais-Govea
Journal:  Sci Rep       Date:  2020-07-29       Impact factor: 4.379

8.  'Turning the tide' on hyperglycemia in pregnancy: insights from multiscale dynamic simulation modeling.

Authors:  Louise Freebairn; Jo-An Atkinson; Yang Qin; Christopher J Nolan; Alison L Kent; Paul M Kelly; Luke Penza; Ante Prodan; Anahita Safarishahrbijari; Weicheng Qian; Louise Maple-Brown; Roland Dyck; Allen McLean; Geoff McDonnell; Nathaniel D Osgood
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05

9.  A novel fast-slow model of diabetes progression: Insights into mechanisms of response to the interventions in the Diabetes Prevention Program.

Authors:  Andrea De Gaetano; Thomas Andrew Hardy
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

10.  Possible role of interleukin-1β in type 2 diabetes onset and implications for anti-inflammatory therapy strategies.

Authors:  Gang Zhao; Gitanjali Dharmadhikari; Kathrin Maedler; Michael Meyer-Hermann
Journal:  PLoS Comput Biol       Date:  2014-08-28       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.